This particular histomorphological feature of glioblastoma is distinct from histological appearances of other tumor types such as melanoma and carcinomas and therefore necessitates development of specific evaluation criteria for readout of immunohistochemical PD-L1 stainings. This evidence concerns the gene CD274 and glioblastoma.